Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuxintongluo Decoction is a traditional Chinese medicine (TCM) herbal formula. It is not a single pharmaceutical compound but rather a multi-herb decoction, typically used in TCM practice for the treatment of cardiovascular and cerebrovascular diseases, especially those associated with "qi deficiency" and "blood stasis" syndromes according to TCM theory. The exact composition may vary by practitioner or region, but such formulas generally aim to invigorate qi (vital energy), promote blood circulation, remove blood stasis, and dredge collaterals (improve microcirculation). Mechanistically, these effects are believed in TCM to support vascular health and neurological function. There is limited high-quality clinical evidence for its efficacy or precise mechanism of action by Western biomedical standards.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuxintongluo Decoction.